klow glow Klow™ Peptide Therapy in Tustin, CA in Tustin, CA GLOW vs KLOW Peptide Blend

HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use

Immunohistochemical analysis When compared to groups treated with GSH-NPs and LS-NPs, the GN treated group showed a significant increase in caspase 3 immunoreactivity

10.1177/0960327120954521 58 LeiD.ChengchengL.XuanQ.YibingC.LeiW.HaoY.et al (2019)

FernndezMartnez, E